| 63 | 0 | 13 |
| 下载次数 | 被引频次 | 阅读次数 |
报道1例肝癌患者因口服盐酸昂丹司琼片致短暂性眼盲的药学实践。患者，女性，58岁，以“反复腹部疼痛半月余，加重2 d”入院，诊断为肝占位性病变（肝癌破裂出血）、左侧肾上腺结节（转移）、慢性乙型病毒性肝炎、肝硬化、腹腔积液、胸腔积液。予经导管肝动脉栓塞术，术后接受抗肿瘤药物治疗。临床药师基于临床症状、实验室检查结果及文献循证，在抗肿瘤药物选择及药物不良反应识别等关键环节实施全程药学监护。治疗期间，患者出现短暂性眼盲，临床药师通过综合分析判断为昂丹司琼片所致不良反应，经及时干预后症状缓解。
Abstract：[1] JIANG C C, YABROFF K R, NIPP R D, et al. Costs and access barriers to ondansetron in the US[J]. JAMA Netw Open, 2024,7(11):e2443978.
[2]马敏明,李盈科,袁红斌.格拉司琼、托烷司琼和昂丹司琼对接受芬太尼自控静脉镇痛患者术后恶心呕吐的预防作用比较[J].中国临床药学杂志, 2020, 29(4):248.
[3] CHEN T T, CHEN C X, ZHOU H, et al. Signal mining of adverse reactions in the antiemetic drug ondansetron during pregnancy:a real-world analysis of the FDA adverse event reporting system(FAERS)[J]. Expert Opin Drug Saf, 2024:1.
[4] HUSSAIN D. QT prolongation with the use of ondansetron:a neglected and overlooked adverse effect[J]. J Pak Med Assoc,2024, 74(5):1013.
[5] BARUS R, POTEY C, GAUTIER S, et al. Ondansetron induced blindness:a pharmacovigilance database study[J]. Expert Opin Drug Saf, 2024, 23(8):1017.
[6]郑伟伟,宋敏,余靓平,等.某院120例5-HT3受体拮抗剂用药分析[J].中国医院药学杂志, 2020, 40(3):339.
[7] JIN X T, BRUNKEN W J. Serotonin receptors modulate rod signals:a neuropharmacological comparison of light-and darkadapted retinas[J]. Vis Neurosci, 1998, 15(5):891.
[8] POOTANAKIT K, BRUNKEN W J. Identification of 5-HT(3A)and 5-HT(3B)receptor subunits in mammalian retinae:potential pre-synaptic modulators of photoreceptors[J]. Brain Res, 2001,896(1-2):77.
[9] KIM J N, NAM J H, LEE J R, et al. The traditional medicine banhasasim-Tang depolarizes pacemaker potentials of cultured interstitial cells of Cajal through M3 muscarinic and 5-HT3 receptors in murine small intestine[J]. Digestion, 2020, 101(5):536.
[10] CHERIAN A, MAGUIRE M. Transient blindness following intravenous ondansetron[J]. Anaesthesia, 2005, 60(9):938.
[11] BABI M A, GORMAN M J, CIPOLLA M J, et al. Ondansetronrelated hemorrhagic posterior reversible encephalopathy syndrome(PRES)following gastric bypass[J]. Springerplus, 2016, 5:18.
[12] CINAR E, SANCI E, UTKU H S, et al. Ondansetron-induced oculogyric crisis in a pediatric patient:case report[J]. CJEM,2023, 25(6):534.
[13]孟康康,夏玉坤.昂丹司琼制剂安全性风险分析[J].中国药物警戒, 2024, 21(9):1034.
基本信息:
DOI：10.19577/j.1007-4406.2025.10.014
中图分类号:R969
引用信息:
[1]蒋艳林,李军,邓俊刚,等.昂丹司琼片致短暂性眼盲1例[J].中国临床药学杂志,2025,34(10):793-795.DOI:10.19577/j.1007-4406.2025.10.014.
基金信息:
广西药品安全科研项目（编号：桂药监科直属[2023]008号）; 广西卫生健康委自筹经费科研课题（编号Z-C20240863）